Literature DB >> 8774801

Platelet activating factor and its role in trauma, shock, and sepsis.

A Ayala1, I H Chaudry.   

Abstract

Platelet activating factor (PAF) is a phospholipid mediator released upon stimulation of cells, such as mast cells, basophils, neutrophils, and macrophages, by opsonized agents. This mediator produces a variety of biological effects and acts via specific binding sites present on various cell types. This article briefly reviews the nature of PAF, as well as what is understood about its role in the inflammatory response associated with trauma, shock, and sepsis. Much of what is known of PAF biology and experimental pathophysiology has come from the discovery and subsequent use of selective PAF antagonists. In this respect, several of the PAF antagonists have been examined experimentally and some have been tested clinically in patients with sepsis and septic shock. Experimental and clinical studies suggest that PAF antagonists appear to be effective in cases of severe Gram-negative septic shock. Nonetheless, this mediator may not be a major component involved in the systemic inflammatory response syndrome.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8774801

Source DB:  PubMed          Journal:  New Horiz        ISSN: 1063-7389


  7 in total

1.  Localization of the platelet-activating factor receptor to rat pancreatic microvascular endothelial cells.

Authors:  B D Flickinger; M S Olson
Journal:  Am J Pathol       Date:  1999-05       Impact factor: 4.307

2.  Interaction of Native- and Oxidized-Low-Density Lipoprotein with Human Estrogen Sulfotransferase.

Authors:  Akira Sato; Hinako Watanabe; Miyuki Yamazaki; Eiko Sakurai; Keiichi Ebina
Journal:  Protein J       Date:  2021-03-04       Impact factor: 2.371

3.  Platelet-activating factor: a previously unrecognized mediator of fever.

Authors:  Andrei I Ivanov; Shreya Patel; Vladimir A Kulchitsky; Andrej A Romanovsky
Journal:  J Physiol       Date:  2003-10-17       Impact factor: 5.182

4.  Efficacy and Safety of the Platelet-Activating Factor Receptor Antagonist BN 52021 (Ginkgolide B) in Patients with Severe Sepsis : A Randomised, Double-Blind, Placebo-Controlled, Multicentre Trial.

Authors:  D M Albrecht; K van Ackern; H-J Bender; H Hof; W Kox; N Victor; P Funk; M Kieser; S Köhler; D Krausch; I Marzi; T Menges; H Schmidt
Journal:  Clin Drug Investig       Date:  2004       Impact factor: 2.859

5.  Estrogen Sulfotransferase is Highly Expressed in Vascular Endothelial Cells Overlying Atherosclerotic Plaques.

Authors:  Akira Sato; Hinako Watanabe; Miyuki Yamazaki; Eiko Sakurai; Keiichi Ebina
Journal:  Protein J       Date:  2022-01-20       Impact factor: 2.371

6.  In vitro anti-inflammatory and anti-coagulant effects of antibiotics towards Platelet Activating Factor and thrombin.

Authors:  Alexandros B Tsoupras; Maria Chini; Nickolaos Tsogas; Athina Lioni; George Tsekes; Constantinos A Demopoulos; Marios C Lazanas
Journal:  J Inflamm (Lond)       Date:  2011-07-07       Impact factor: 4.981

Review 7.  Factor XII-Driven Inflammatory Reactions with Implications for Anaphylaxis.

Authors:  Lysann Bender; Henri Weidmann; Stefan Rose-John; Thomas Renné; Andy T Long
Journal:  Front Immunol       Date:  2017-09-15       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.